Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Stephen V. Liu is an Assistant Professor of Medicine and a practicing thoracic medical oncologist at the Lombardi Comprehensive Cancer Center at Georgetown University. He received his undergraduate degree at Johns Hopkins University and his medical degree at the University of Maryland. He then completed his internship and residency in Internal Medicine at the University of Pennsylvania and his fellowship training in Hematology and Oncology at the University of Southern California before joining the faculty of Georgetown University. Dr.
Lung Cancer Video Library - Continuing Immunotherapy Beyond Progression In Which Patients Is This Appropriate
dbrock
We are pleased to have Dr. Stephen Liu bring us further updates for our 2017 Lung Cancer Video Library.
Dr. Liu, a board-certified medical oncologist, specializes in lung cancer, cancers of the head and neck, and skin. Dr. Liu is a strong advocate of genomic testing to identify actionable mutations leading to the most effective, targeted therapies for personalized care. He is the recipient of many teaching and patient care awards.
In this latest video, Dr. Liu discusses Continuing Immunotherapy Beyond Progression In Which Patients Is This Appropriate.
We would like to thank the following companies for their support of this program
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
This live virtual event, led by Dr. Andrew Srisuwananukorn on October 25, 2025, brought together top oncologists to share the latest updates in blood cancer treatment. The program featured patient-focused presentations, expert panel discussions, and a real-time Q&A session where attendees could engage directly with specialists.
To watch the complete playlist, click here.
Image
Video
In this video series led by Dr. Siddharth Sheth and recorded on October 27, 2025, a panel of leading oncologists engages in a dynamic and insightful roundtable discussion as they share newly released data, key highlights, and significant developments in head and neck cancer treatment while addressing the most pressing questions, delivered in a concise and easy-to-understand format.
To watch the complete playlist, click here.
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
In this 2nd series of videos, Michael Herman takes us through the story of his diagnosis, his struggles with treatment options, his clinical trial and his learning curve.
Thank you to our Sponsors! #lilly #exelixis
Online Community
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.